CN111097030A - Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof Download PDF

Info

Publication number
CN111097030A
CN111097030A CN202010056679.1A CN202010056679A CN111097030A CN 111097030 A CN111097030 A CN 111097030A CN 202010056679 A CN202010056679 A CN 202010056679A CN 111097030 A CN111097030 A CN 111097030A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
cancer
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010056679.1A
Other languages
Chinese (zh)
Inventor
刘彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010056679.1A priority Critical patent/CN111097030A/en
Publication of CN111097030A publication Critical patent/CN111097030A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating tumors and relieving tumor pain and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine components in parts by weight: 30-180 parts of astragalus membranaceus, 10-90 parts of rhizoma sparganii, 10-90 parts of curcuma zedoary, 10-90 parts of frankincense, 10-90 parts of myrrh, 10-90 parts of cornus officinalis, 10-90 parts of bighead atractylodes rhizome, 10-90 parts of endothelium corneum gigeriae galli, 10-90 parts of achyranthes bidentata, 10-90 parts of platycodon grandiflorum and 10-90 parts of liquorice; the preparation method comprises cleaning the above materials, sun drying, grinding into fine powder, mixing, and making into pill (3 g per pill). The formula combination formula of the invention is rigorous, the efficacy is comprehensive, and the efficacy is special; the main and central cancer-treating guidelines are yang-qi supporting, stomach-qi protecting, and body fluids storing, and are carried out throughout. Has good therapeutic effect on lung cancer, gastric cancer, hepatocarcinoma, colorectal cancer, breast cancer, esophageal cancer, pancreatic cancer, brain cancer, lymph cancer, and prostatic cancer.

Description

Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating tumors and relieving tumor pain and a preparation method thereof.
Background
Tumor is a common disease and frequently encountered disease, and is a new organism formed by abnormal hyperplasia caused by the loss of normal regulation and control on the growth of cells of local tissues on the gene level under the action of various tumorigenic factors of an organism. Tumors have become a major disease species seriously threatening human health, and the morbidity and mortality of the tumors tend to rise year by year. With the increase of age, the morbidity and mortality of men and women in China gradually increase. The traditional Chinese medicine is a powerful weapon for preventing and treating diseases in traditional Chinese medicine, and the traditional Chinese medicine has good effects on relieving clinical symptoms, improving the quality of life, preventing recurrence and metastasis, prolonging the life cycle, cooperating with radiotherapy and chemotherapy, enhancing the efficacy, reducing toxicity and the like when used for treating tumors. The Chinese herbal compound is a main means for preventing and treating diseases of the traditional Chinese medicine. In recent years, the compound and the redevelopment of the compound become important means of antitumor therapy, the curative effect is maximized by selecting the effective components of the antitumor traditional Chinese medicine with different action mechanisms and the synergistic effect, the resistance threshold of tumor cells is reduced, and the foundation is laid for the modern development and research of the traditional Chinese medicine.
Disclosure of Invention
The invention discloses a traditional Chinese medicine composition for treating tumors and relieving tumor pain and a preparation method thereof. The invention aims to provide a traditional Chinese medicine compound composition and a preparation method thereof, and the traditional Chinese medicine has good effects of treating and relieving pain for lung cancer, gastric cancer, liver cancer, colorectal cancer, breast cancer, esophageal cancer, pancreatic cancer, brain cancer, lymph cancer and prostate cancer.
The invention is realized by the following technical scheme:
the traditional Chinese medicine composition for treating tumors and relieving tumor pain is characterized by being prepared from the following traditional Chinese medicine components in parts by weight: 30-180 parts of astragalus membranaceus, 10-90 parts of rhizoma sparganii, 10-90 parts of curcuma zedoary, 10-90 parts of frankincense, 10-90 parts of myrrh, 10-90 parts of cornus officinalis, 10-90 parts of bighead atractylodes rhizome, 10-90 parts of endothelium corneum gigeriae galli, 10-90 parts of achyranthes bidentata, 10-90 parts of platycodon grandiflorum and 10-90 parts of liquorice.
The traditional Chinese medicine composition is further prepared from the following traditional Chinese medicine components in parts by weight: 60 parts of astragalus membranaceus, 15 parts of rhizoma sparganii, 15 parts of curcuma zedoary, 15 parts of frankincense, 15 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice.
Furthermore, the traditional Chinese medicine composition can also be prepared from the following traditional Chinese medicine components in parts by weight: 90 parts of astragalus membranaceus, 15 parts of rhizoma sparganii, 15 parts of curcuma zedoary, 60 parts of frankincense, 60 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice. The medicine composition is applied to preparing the medicine for treating the pain aggravation condition of middle and late stage tumor patients, and particularly has the effect of relieving the tumor pain.
Furthermore, the traditional Chinese medicine composition can also be prepared from the following traditional Chinese medicine components in parts by weight: 90 parts of astragalus membranaceus, 45 parts of rhizoma sparganii, 45 parts of curcuma zedoary, 45 parts of frankincense, 45 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice. The medicine composition is applied to preparing medicines for treating large lumps of patients with middle and late stage tumors accompanied by high blood viscosity, high blood fat, high blood sugar, high blood uric acid and the like, and has obvious treatment and alleviation effects.
The preparation method of the traditional Chinese medicine composition for treating tumors comprises the following steps: cleaning the medicinal materials, drying in the sun, grinding into fine powder, mixing, and making into pill (3 g per pill).
The traditional Chinese medicine composition for treating tumors comprises the following components:
the astragalus root tonifies qi and blood, treats qi and blood, supports sores and promotes tissue regeneration, and leads other medicines;
the rhizoma sparganii and the curcuma zedoary have good effects on qi and blood stagnation and long-term blood stasis accumulation, and the rhizoma sparganii and the curcuma zedoary obtain the astragalus and the red ginseng, so that the effects of breaking blood and activating blood are enhanced, but qi and blood are not damaged;
olibanum and Myrrha are good medicines for dispersing and relieving pain of viscera and meridians, and they are used for treating pain in chest, middle and abdomen. The frankincense and the myrrh are prepared from astragalus root, have double dredging force and tonify and dredge, and are good medicines for treating cancer pain;
corni fructus is the first herb to restore yang and relieve collapse, and can astringe primordial qi but not pathogenic qi, induce resuscitation and circulate blood. The cornus officinalis is astragalus mongholicus, one liter of the cornus officinalis is astringed, qi is benefited and kidney is strengthened, and the cornus officinalis is capable of rescuing and relieving collapse, prolonging the life of a patient suffering from extreme weak middle and late stage cancer, and has a great effect;
the largehead atractylodes rhizome is a main drug for tonifying and strengthening the spleen and stomach, and the chicken's gizzard-membrane is good at eliminating the stasis of the spleen and stomach, and has the effects of tonifying and eliminating the spleen and stomach, reinforcing the middle energizer and strengthening the spleen and stomach. The largehead atractylodes rhizome and the chicken's gizzard-membrane are astragalus which are dependent on each other in ascending and descending, are combined with each other in tonifying and digestion, greatly improve the capability of strengthening the spleen and stomach, are beneficial to the appetite and the robustness of cancer patients and lay a solid foundation for the long-term survival of the cancer patients.
Niu xi is good at moving downward and good at guiding blood and fire downward. Jiefang san, radix Platycodi, pungent in flavor and pungent in flavor, can disperse lung qi, promote the ascending of herbs and "Zhouyi agent", which can promote the ascending and descending of herbs and make the potency of herbs reach the whole body. The two medicines are prepared from radix astragali, and the ascending and descending force of the guiding medicine is greatly increased.
Guo Lao gan Cao has sweet taste and mild nature, and is good at harmonizing the strong and toxic properties of some herbs. The liquorice is the astragalus root, and has the effects of tonifying qi, benefiting lung, detoxifying, promoting tissue regeneration and greatly increasing strength.
The formula composition of the invention has the following characteristics and benefits:
firstly, the traditional Chinese medicine is economical and practical, has low price, brings good news to increasing cancer patients in China, and finds a way for continuously struggling with diseases and evil for a plurality of difficult families with 'poor return due to cancer';
the second is the formula of 11 medicines, the prescription is precise, the efficacy is comprehensive, and the efficacy is special.
1. The "strengthening yang qi, protecting stomach qi and preserving body fluids" is used as the principal and central cancer-treating guideline of this formula and is carried out throughout.
The kidney is the congenital origin, the stomach is the acquired origin, and the functions of supporting yang and protecting stomach are performed all the time because they are the human root! By "reserve body fluid" we understand to reduce the damage to the positive energy of yin and yang, such as yang qi, essence and blood, such as inability to perspire, insist on sweating, inability to attack, and insist on attacking, i.e. the treatment must consider the appropriateness and rationality of the highest specification to avoid innocent damage to the patient's body!
In the formula, the combination of astragalus root, cornus fruit and achyranthes root is the direct embodiment of strengthening yang qi. Radix astragali greatly supplements primordial qi, amplifies the effects of the cornus and the achyranthes, and the cornus tonifies the kidney and strengthens the kidney, which is the first medicine for rescuing from collapse by restoring yang; achyranthes root, radix Achyranthis bidentatae removes blood stasis, promotes menstruation, tonifies liver and kidney, and strengthens muscles and bones; the combination of astragalus root, cornus fruit and achyranthes root fully embodies the strategic ideas of reinforcing the kidney and strengthening yang and strengthening the congenital foundation.
In the formula, the combination of astragalus root, bighead atractylodes rhizome and chicken's gizzard-membrane is the direct embodiment of protecting stomach qi. The largehead atractylodes rhizome is a main drug for tonifying and strengthening the spleen and stomach, and the chicken's gizzard-membrane is good at eliminating the stasis of the spleen and stomach, and has the effects of tonifying and eliminating the spleen and stomach, reinforcing the middle energizer and strengthening the spleen and stomach. The largehead atractylodes rhizome and the chicken's gizzard-membrane are astragalus which are dependent on each other in ascending and descending, have the effects of tonifying and eliminating, greatly increase the capability of strengthening the spleen and stomach, are beneficial to strengthening the appetite of cancer patients and lay a solid foundation for the long-term survival of the cancer patients, namely ' good eating and body fluid generation '; long time eating can lead to long-term survival.
The eleven traditional Chinese medicines in the recipe have no drastic sweating, purgative, diuretic and toxic herbs, so the important ideas of storing and preserving body fluid can be seen. Only if the body fluid is sufficient, the cancer patient can live well and for a long time.
2. For cancer, the recipe takes the 16-character formula of regulating qi, relieving depression, promoting blood circulation, removing blood stasis, eliminating phlegm, removing dampness, softening hardness and expelling toxin as the main means of treating cancer while following the above guidelines for treating cancer.
For cancer, it is not enough to follow the treatment guidelines of "strengthening yang qi, protecting stomach qi, and storing body fluid" at night, and at this time, the operative guidelines of "entering collaterals for a long time, being deficient for a long time, causing long time symptoms and stasis, causing strange diseases and asking for water, and causing many diseases and not being treated by kidney" are very important, so for the treatment of cancer, the method embodies the 16-character criteria of "regulating qi and resolving stagnation, activating blood and dissolving stasis, removing phlegm and dampness, softening hardness and expelling toxin".
In the formula, the astragalus is matched with the rhizoma sparganii, the curcuma zedoary, the frankincense and the myrrh, namely a good medicine for regulating qi, resolving depression, activating blood, removing stasis, softening hardness and expelling toxin, most cancers are silted, nodules and tumor bodies, so that the problems which need to be solved in the treatment process of qi depression, blood stasis and toxin stasis are solved, and the astragalus is matched with the rhizoma sparganii, the curcuma zedoary, the frankincense and the myrrh to attack and tonify, not only kills tumors, but also does not hurt the body resistance, so the compatibility is a good strategy for attacking cancers;
in the formula, the astragalus, the endothelium corneum gigeriae galli and the bighead atractylodes rhizome are good formulas for removing phlegm, dehumidifying, softening hard masses and expelling toxin. The combination of chicken's gizzard-membrane is good at eliminating the accumulation in the chest and abdomen, and astragalus root and white atractylodes rhizome are good at eliminating the damp toxin in the body, so that the cancer caused by the phlegm dampness can be treated without suspicion.
3. The recipe has strict compatibility, strict logic and bright and macro efficacy.
The monarch, minister, assistant and guide medicines of the formula are rigorous, and the astragalus root is the monarch, so that the core and the ultimate concept of 'strengthening yang and consolidating basis' are embodied;
ministerial drugs, adjuvant drugs, namely rhizoma sparganii, curcuma zedoary, frankincense, myrrh, cornus officinalis, endothelium corneum gigeriae galli and bighead atractylodes rhizome have the effects of reinforcing and attacking, and reinforcing and complementing mutually, and the degree of law is strict, so that the respective efficacies of the astragalus are multiplied;
so that achyranthes and platycodon root can strengthen the kidney and regulate the lung, and the ascending and descending force of the medicines is increased, so that the medicine strength is greatly increased and reaches the focus directly; the liquorice root, radix astragali, which is a guiding drug, coordinates the effects of the other drugs in the recipe to obtain the astragalus root, and also has the effects of tonifying qi, benefiting lung, detoxifying, promoting tissue regeneration and greatly increasing the efficacy.
Detailed Description
The present invention is further described below in conjunction with the following detailed description, which is intended to further illustrate the principles of the invention and is not intended to limit the invention in any way, but is equivalent or analogous to the present invention without departing from its scope.
Preparation examples
The traditional Chinese medicine composition is prepared according to the following steps:
taking 60g of astragalus, 15g of rhizoma sparganii, 15g of curcuma zedoary, 15g of frankincense, 15g of myrrh, 15g of cornus officinalis, 15g of bighead atractylodes rhizome, 15g of endothelium corneum gigeriae galli, 15g of achyranthes, 15g of platycodon grandiflorum and 15g of liquorice.
Cleaning the above materials, oven drying, respectively grinding into fine powder, mixing, and making into pill with 3g per pill by conventional method.
The traditional Chinese medicine composition with other contents is prepared by the same method.
Case one:
zhu lady, 90 years old, has confirmed liver cancer late stage, carcinoembryonic antigen (CEA)18.2ug/L, Alpha Fetoprotein (AFP)8.6 ug/L.
First diagnosis:
the body temperature is 37 degrees, aversion to wind, aversion to cold, general weakness, listlessness, no sweat, abdominal distension, abdominal dropsy and edema of two legs during the treatment. Chronic diseases such as hypertension, hyperlipidemia, renal calculus and the like exist, stroke is caused once, and the action of the left lower limb is limited; the four diagnostic methods are combined: late stage hepatocarcinoma, abdominal cavity and chest distention, no severe pain, aversion to cold, aversion to wind, low fever, no sweat, emaciation, cold limbs, pale red tongue, white greasy fur, and deep weak pulse.
The treatment scheme comprises the following steps:
the traditional Chinese medicine composition comprises 90g of astragalus, 45g of rhizoma sparganii, 45g of curcuma zedoary, 15g of frankincense, 15g of myrrh, 15g of cornus officinalis, 15g of bighead atractylodes rhizome, 15g of endothelium corneum gigeriae galli, 15g of achyranthes root, 15g of platycodon grandiflorum and 15g of liquorice. Pulverizing into powder, and making into pill (3 g per pill) which is taken 3 times a day (3-6 pills per time) with warm water.
And B, diagnosis:
after one month, the patient has a second visit with abdominal swelling, abdominal dropsy, edema in both legs, aversion to wind, aversion to cold, good recovery, good spirit and good appetite.
The medicine is taken 3 times a day, 3 pills each time, and is taken with warm water.
Three diagnoses:
after the second diagnosis, the patients see the diagnosis again after two months, and the symptoms of various physical malaise obviously disappear, the carcinoembryonic antigen (CEA) is 7.6ug/L, and the Alpha Fetoprotein (AFP) is 6.1 ug/L.
The medicine is taken 3 times a day, 3 pills each time, and is taken with warm water.
Case two:
tang dynasty women, age 65, had confirmed the advanced stage of lung cancer and cancer cells metastasized to the pleuroperitoneal cavity and lymph. Lung cancer tumor index (Cyfra21-1)6.5ng/ml, carcinoembryonic antigen (CEA)18.2ug/L, Alpha Fetoprotein (AFP)8.6 ug/L.
First diagnosis:
the body temperature is 36.8 degrees at the time of treatment, the patient feels hot at the time of treatment, coughs, and has a lot of yellow and blood-carrying phlegm, thick phlegm and phlegm-clearing impurities, dizziness, blurred vision, general weakness and severe pain in chest and abdomen. The four diagnostic methods are combined: late stage lung cancer, severe pain in chest and abdomen, aversion to cold and wind, cold limbs, alternating chills and fever, poor appetite, pale red tongue with thick white coating, deep and thready pulse.
The traditional Chinese medicine composition comprises 90g of astragalus, 15g of rhizoma sparganii, 15g of curcuma zedoary, 60g of frankincense, 60g of myrrh, 15g of cornus officinalis, 15g of bighead atractylodes rhizome, 15g of endothelium corneum gigeriae galli, 15g of achyranthes root, 15g of platycodon grandiflorum and 15g of liquorice. Pulverizing into powder, and making into pill (3 g per pill) which is taken 3 times a day (3-6 pills per time) with warm water.
And B, diagnosis:
after two months, the patients have a re-diagnosis, and the severe pain in chest and abdomen, cough, sputum, aversion to wind and cold, spiritual and good appetite are obviously relieved.
The medicine is taken 3 times a day, 3 pills each time, and is taken with warm water.
Three diagnoses:
after the second diagnosis is finished for two months, patients are re-diagnosed, various discomforts are obviously relieved, the lung cancer tumor index (Cyfra21-1) is 5.5ng/ml, the carcinoembryonic antigen (CEA) is 9.2ug/L, and the Alpha Fetoprotein (AFP) is 7.6 ug/L.
The medicine is taken 3 times a day, 3 pills each time, and is taken with warm water.

Claims (5)

1. A traditional Chinese medicine composition for treating tumors and relieving tumor pain is characterized by being prepared from the following traditional Chinese medicine components in parts by weight: 30-180 parts of astragalus membranaceus, 10-90 parts of rhizoma sparganii, 10-90 parts of curcuma zedoary, 10-90 parts of frankincense, 10-90 parts of myrrh, 10-90 parts of cornus officinalis, 10-90 parts of bighead atractylodes rhizome, 10-90 parts of endothelium corneum gigeriae galli, 10-90 parts of achyranthes bidentata, 10-90 parts of platycodon grandiflorum and 10-90 parts of liquorice.
2. The traditional Chinese medicine composition for treating tumors and relieving tumor pain according to claim 1, which is characterized by being prepared from the following traditional Chinese medicine components in parts by weight: 60 parts of astragalus membranaceus, 15 parts of rhizoma sparganii, 15 parts of curcuma zedoary, 15 parts of frankincense, 15 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice.
3. The traditional Chinese medicine composition for treating tumors and relieving tumor pain according to claim 1, which is characterized by being prepared from the following traditional Chinese medicine components in parts by weight: 90 parts of astragalus membranaceus, 15 parts of rhizoma sparganii, 15 parts of curcuma zedoary, 60 parts of frankincense, 60 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice.
4. The traditional Chinese medicine composition for treating tumors and relieving tumor pain according to claim 1, which is characterized by being prepared from the following traditional Chinese medicine components in parts by weight: 90 parts of astragalus membranaceus, 45 parts of rhizoma sparganii, 45 parts of curcuma zedoary, 45 parts of frankincense, 45 parts of myrrh, 15 parts of cornus officinalis, 15 parts of bighead atractylodes rhizome, 15 parts of endothelium corneum gigeriae galli, 15 parts of achyranthes bidentata, 15 parts of platycodon grandiflorum and 15 parts of liquorice.
5. A preparation method of a traditional Chinese medicine composition for treating tumors and relieving tumor pain is characterized by comprising the following steps: the traditional Chinese medicine composition is the traditional Chinese medicine composition of any one of claims 1 to 4, and the preparation method comprises the following steps: cleaning the medicinal materials, drying in the sun, grinding into fine powder, mixing, and making into pill (3 g per pill).
CN202010056679.1A 2020-01-18 2020-01-18 Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof Pending CN111097030A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010056679.1A CN111097030A (en) 2020-01-18 2020-01-18 Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010056679.1A CN111097030A (en) 2020-01-18 2020-01-18 Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111097030A true CN111097030A (en) 2020-05-05

Family

ID=70427374

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010056679.1A Pending CN111097030A (en) 2020-01-18 2020-01-18 Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111097030A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113663037A (en) * 2021-09-14 2021-11-19 临沧宏胜生物科技开发有限公司 Traditional Chinese medicine composition for inhibiting gastric cancer cell metastasis and preparation method thereof
CN115804823A (en) * 2022-12-23 2023-03-17 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating cervical precancerous lesions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
何敏婉: "四逆散治疗癌症疼痛验案 3则", 《河北中医》 *
康 超等: "健脾补肾汤联合GP方案治疗鳞状细胞肺癌33 例", 《现代中医药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113663037A (en) * 2021-09-14 2021-11-19 临沧宏胜生物科技开发有限公司 Traditional Chinese medicine composition for inhibiting gastric cancer cell metastasis and preparation method thereof
CN115804823A (en) * 2022-12-23 2023-03-17 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating cervical precancerous lesions
CN115804823B (en) * 2022-12-23 2024-02-06 广东罗浮山国药股份有限公司 Traditional Chinese medicine composition for treating cervical cancer precursor lesions

Similar Documents

Publication Publication Date Title
CN101745065B (en) Pharmaceutical composition with effects of resisting cancer and alleviating pain
CN101181529B (en) Chinese medicine composition for curing tumor and preparation method thereof
CN111097030A (en) Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof
CN105213974A (en) One treats lymphadenomatous Chinese medicine composition and application thereof
CN104288255A (en) Traditional Chinese medicine preparation for treating severe acute pancreatitis
CN107596331A (en) A kind of Chinese medicine preparation and preparation method for treating stomach cancer
CN103735745B (en) Traditional Chinese medicine formulation for treating lung tumor and preparation method of traditional Chinese medicine formulation
CN111407872A (en) Traditional Chinese medicine composition for treating liver cancer, medicine for treating liver cancer and preparation method of medicine
CN103083387A (en) Congestion-eliminating pain-relieving plaster
CN113082168A (en) Pharmaceutical composition for treating lung cancer and application thereof
CN106822733B (en) Ointment for treating precancerous lesion of chronic atrophic gastritis and preparation method thereof
CN115154576B (en) Traditional Chinese medicine composition for treating malignant tumor-associated diarrhea
CN101530589B (en) Chinese medicinal preparation for treating cancers
CN106938031A (en) A kind of medicine of thyroid adenoma
CN106039236A (en) Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation
CN105833228A (en) Drug preparation for reversing gastric cancer drug resistance and application thereof
CN106236873A (en) A kind of Chinese medicine composition treating disease of stomach
CN105434533A (en) Traditional Chinese medicine composition for treating liver cancer
CN105878936A (en) Anti-tumor traditional Chinese medicine composition
CN113925947A (en) Traditional Chinese medicine formula for treating liver cancer
CN115282247A (en) Traditional Chinese medicine for treating advanced cancer and preparation method thereof
CN104800693B (en) A kind of Chinese medicine composition for treating lung cancer
CN104306439A (en) Plaster for treating tumor and preparation method of plaster
CN110507788A (en) A kind of Chinese medicine composition and preparation method thereof for treating gastric cancer
CN101468197B (en) Medicament for treating tumor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200505

RJ01 Rejection of invention patent application after publication